New acute treatments for headache

被引:0
作者
Alan M. Rapoport
机构
[1] The David Geffen School of Medicine at UCLA,
来源
Neurological Sciences | 2010年 / 31卷
关键词
Acute treatment of migraine; Migraine therapy; CGRP antagonist; Iontophoretic patch; Needle free injection; Sumatriptan; DHE; Oral inhalation;
D O I
暂无
中图分类号
学科分类号
摘要
Although we have several acute care medications for the treatment of migraine, we are always looking for new medications to treat our patients. Patients often say that their headaches are not under optimal control and would be happy to try another medication. Patients look for faster onset of relief, more complete relief, no recurrent headache and no adverse events. This article will cover some new and some anticipated acute care products, CGRP antagonists, sumatriptan by iontophoretic patch, sumatriptan by needle-free injections, DHE by oral inhalation and diclofenac potassium in a sachet. Botulinum toxin therapy, although a preventive measure, will be mentioned at the end.
引用
收藏
页码:129 / 132
页数:3
相关论文
共 29 条
[1]  
Ramadan NM(2006)New and future migraine therapy Pharmacol Ther 112 199-212
[2]  
Buchanan TM(1993)The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats Ann Neurol 33 48-56
[3]  
Goadsby PJ(2005)Calcitonin gene related peptide does not excite or sensitize meningeal nociceptors: implications for the pathophysiology of migraine Ann Neurol 58 698-705
[4]  
Edvinsson L(2004)Calcitonin gene related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine N Engl J Med 350 1104-1110
[5]  
Levy D(2008)Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine Neurology 70 1304-1312
[6]  
Burstein R(2008)Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial Lancet 372 2089-2090
[7]  
Strassman AM(2009)Antimigraine drugs: new frontiers Neurol Sci 30 S49-S54
[8]  
Olesen J(2007)Aerosol delivery of ergotamine tartrate via a breath-synchronized plume-control inhaler in humans Curr Med Res Opin 23 3177-3187
[9]  
Diener HC(2008)Safety and pharmacokinetics of dihydroergotamine mesylate administered via a novel (TEMPO_) Inhaler Headache 48 355-367
[10]  
Husstedt IW(2005)Botulinum toxin type A for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study Headache 45 315-324